MX2009004775A - Nuevos compuestos y metodos para su produccion. - Google Patents

Nuevos compuestos y metodos para su produccion.

Info

Publication number
MX2009004775A
MX2009004775A MX2009004775A MX2009004775A MX2009004775A MX 2009004775 A MX2009004775 A MX 2009004775A MX 2009004775 A MX2009004775 A MX 2009004775A MX 2009004775 A MX2009004775 A MX 2009004775A MX 2009004775 A MX2009004775 A MX 2009004775A
Authority
MX
Mexico
Prior art keywords
production
diseases
methods
novel compounds
cancer
Prior art date
Application number
MX2009004775A
Other languages
English (en)
Spanish (es)
Inventor
Christine Martin
Original Assignee
Biotica Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0622342.4A external-priority patent/GB0622342D0/en
Priority claimed from GB0720875A external-priority patent/GB0720875D0/en
Application filed by Biotica Tech Ltd filed Critical Biotica Tech Ltd
Publication of MX2009004775A publication Critical patent/MX2009004775A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2009004775A 2006-11-09 2007-11-09 Nuevos compuestos y metodos para su produccion. MX2009004775A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0622342.4A GB0622342D0 (en) 2006-11-09 2006-11-09 Novel compounds and methods for their production
GB0720875A GB0720875D0 (en) 2007-10-24 2007-10-24 Novel compounds and methods for their production
PCT/GB2007/050679 WO2008056188A2 (en) 2006-11-09 2007-11-09 Novel compounds and methods for their production

Publications (1)

Publication Number Publication Date
MX2009004775A true MX2009004775A (es) 2009-05-21

Family

ID=39362724

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004775A MX2009004775A (es) 2006-11-09 2007-11-09 Nuevos compuestos y metodos para su produccion.

Country Status (10)

Country Link
US (1) US8492370B2 (cg-RX-API-DMAC10.html)
EP (1) EP1973883B1 (cg-RX-API-DMAC10.html)
JP (1) JP2010509306A (cg-RX-API-DMAC10.html)
KR (1) KR20090075856A (cg-RX-API-DMAC10.html)
AU (1) AU2007319014B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0718564A2 (cg-RX-API-DMAC10.html)
CA (1) CA2669047A1 (cg-RX-API-DMAC10.html)
ES (1) ES2389740T3 (cg-RX-API-DMAC10.html)
MX (1) MX2009004775A (cg-RX-API-DMAC10.html)
WO (1) WO2008056188A2 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2121957A4 (en) * 2007-01-26 2010-11-10 Kosan Biosciences Inc MACROLACTAMES OBTAINED BY MODIFIED BIOSYNTHESIS
KR101097850B1 (ko) 2009-02-24 2011-12-23 한국생명공학연구원 젤다나마이신 생합성 조절유전자 변이주 및 이를 이용한 젤다나마이신 생산방법
CN117695374B (zh) * 2024-01-25 2024-09-06 超越健康科技(浙江)有限公司 一种用于治疗帕金森病的生物药物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9401936D0 (en) * 1992-01-06 1994-09-28 Pfizer Process and uses for 4,5-diohydrogeldanamycin and its hydroquinone
US7465718B2 (en) * 2002-02-08 2008-12-16 Conforma Therapeutics Corporation Ansamycins having improved pharmacological and biological properties
US7282493B2 (en) 2003-12-23 2007-10-16 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
JPWO2005061461A1 (ja) * 2003-12-24 2007-07-12 協和醗酵工業株式会社 ヒートショックプロテイン９０（ｈｓｐ９０）ファミリー蛋白質阻害剤
WO2006098761A2 (en) 2005-03-11 2006-09-21 The Regents Of The University Of Colorado Hsp90 inhibitors, methods of making and uses therefor
KR20080027896A (ko) * 2005-06-29 2008-03-28 교와 핫꼬 고교 가부시끼가이샤 벤제노이드 안사마이신 유도체
WO2007074347A1 (en) 2005-12-24 2007-07-05 Biotica Technology Ltd. 21-deoxymacbecin analogues useful as antitumor agents
CN101012196A (zh) * 2006-12-27 2007-08-08 中国人民解放军军事医学科学院毒物药物研究所 芳香化格尔德霉素类衍生物及其制备方法和用途
EP2121957A4 (en) * 2007-01-26 2010-11-10 Kosan Biosciences Inc MACROLACTAMES OBTAINED BY MODIFIED BIOSYNTHESIS

Also Published As

Publication number Publication date
ES2389740T3 (es) 2012-10-31
AU2007319014A1 (en) 2008-05-15
KR20090075856A (ko) 2009-07-09
US20110021481A1 (en) 2011-01-27
EP1973883B1 (en) 2012-07-11
WO2008056188A3 (en) 2008-07-31
BRPI0718564A2 (pt) 2014-03-11
JP2010509306A (ja) 2010-03-25
CA2669047A1 (en) 2008-05-15
AU2007319014B2 (en) 2013-03-28
WO2008056188A2 (en) 2008-05-15
US8492370B2 (en) 2013-07-23
EP1973883A2 (en) 2008-10-01

Similar Documents

Publication Publication Date Title
JO2931B1 (en) Double-substituted phthalazin compounds as antagonists of the cell-specific factor pathway
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
PH12012500497A1 (en) Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs
MX2009009936A (es) Amino piridina fusionada como inhibidores de hsp90.
MX2010002312A (es) Compuestos de triazolopiridina y su uso como inhibidores de cinasa reguladora de señal de apoptosis.
TW200716646A (en) (S)-N-methylnaltrexone
TW200508201A (en) Novel process for the preparation of roflumilast
NZ708727A (en) Conjugate compounds
MX2011011342A (es) Compuestos de vinil indazolilo.
MY186456A (en) Quinazoline carboxamide azetidines
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
WO2008095086A3 (en) Topiramate plus naltrexone for the treatment of addictive disorders
TNSN07143A1 (en) Aqueous, radiation-hardenable resins, method for the production thereof, and use of the same
EA201170699A1 (ru) Тетразамещенные пиридазины в качестве антагонистов пути hedgehog
GEP20115293B (en) Isolated extract of walnuts, process for its obtaining and its use
EP2416795A4 (en) COGNITIVE DECLINE INHIBITORS
MX2009009362A (es) Forma de dosificacion novedosa.
MX2009000991A (es) Uso de escina.
UA97401C2 (ru) Экструдат с улучшенной маскировкой вкуса
WO2007128829A3 (en) 18,21-didesoxymacbecin derivatives for the treatment of cancer
AU2013212209A8 (en) (1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
MX2009004777A (es) Derivados de 18,21-didsesoximacbecina para el tratamiento de cancer.
MX2009009361A (es) Nueva forma de dosificacion.
WO2008056188A3 (en) Novel compounds and methods for their production

Legal Events

Date Code Title Description
FG Grant or registration